Neurology
Latest News


Nerivio Neuromodulation Device Maintains Efficacy, Safety at 1 Year of Consistent Use for Migraine
By Marco Meglio

Ubrogepant Taken During Migraine Prodrome Reduces Headache Severity: Phase 3 Clinical Trial
By Marco Meglio
Advertisement



































































































































